The Institute for Clinical and Economic Review (ICER) has rescheduled its public meeting on cystic fibrosis treatments to Aug. 27. According to a press release, the meeting, which had originally been postponed due to the COVID-19 pandemic, will take place online. To read the full press […]
NPC Webinar on COVID-19 Prices Nears
The National Pharmaceutical Council's webinar on COVID-19 drug prices is less than a week away. Registration for the event remains open. "It's Time to Talk about COVID-19 Prices" is set for 3:30 p.m. EST July 24. Panelists include: Peter Bach, MD, MAPP, Director, Center for Health Policy […]
NICE Clinical Fellow Ali Highlights Sustainability Efforts
Fizzah Ali, a medical clinical fellow at the U.K.'s National Institute for Health and Care Excellence, discusses how the Sustainability Steering Group (SSG) is working toward a greener future. "Promoting sustainable implementation of guidance recommendations and obtaining information on […]
ISPOR to Host Webinar on Drug, Device Utilization Amid Pandemic
The International Society for Pharmacoeconomics and Outcomes Research is set to host a July 28 webinar highlighting the COVID-19 pandemic's impact on drug and medical device utilization. "Assessing the Impacts of a Pandemic on Pharmaceutical and Medical Device Utilization" is set to being 11 a.m. […]
Medidata, CTI Partner on Remote Trial Reviews
CTI Clinical Trial Solutions and Consulting Services is partnering with Medidata to facilitate remote monitoring and reviews for clinical trials across the globe. According to a press release, CTI will utilize Medidata's Remote Source Review solution. "Medidata is committed to developing and […]
NPC, Duke-Margolis Center for Health Policy Name New Health Policy Fellow
The National Pharmaceutical Council (NPC) and Duke-Margolis Center for Health Policy recently named Salama Freed as the 2020-22 post-doctoral health policy fellow. According to a press release, the fellowship is "designed to bridge a persistent gap between health research and policy […]
IFAPP Academy, MAPS Offer Medical Affairs Course
IFAPP Academy and the Medical Affairs Professional Society (MAPS) are offering an online course for medical affairs professionals looking to expand their knowledge on drug development. Applications for the course, "Introduction to Medical Affairs in Medicines Development," will be accepted until […]
Measuring Care Value
Stacey Richter, Relentless Health Value host and Aventria Health Group co-founder, discusses metrics for measuring care value in the latest Relentless Health Value installment. The metrics used to measure care value are "critical," Richter says. " ... American health care is the biggest most […]
Cytel COVID-19 Clinical Development Quiz
Cytel is offering a quiz for users to gauge their knowledge on the state of COVID-19 clinical development across the globe. "There are currently 1570 registered clinical trials for COVID-19 therapies and vaccines," a description states. "Approximately 20% are registered in the United States and […]
OptumRx’s Calabrese: Top 3 Drugs in Pipeline
OptumRx Senior Vice President and Chief Pharmacy Officer David Calabrese in a recent interview with Managed Healthcare Executive discusses the top three drugs in the pipeline. To listen to the full discussion on Managed Healthcare Executive, click here. […]
ACS Researchers Receive RWD Award
Three American Cancer Society researchers have been awarded the Real-World Data Impact Award, ACS and Flatiron Health announced this week. The recipients of the awards are: Minal Kale, Icahn School of Medicine at Mount Sinai; Siran Koroukian-Hajinazarian, Case Western Reserve University […]
McClellan Stresses Need for RWE Infrastructure
Duke-Margolis' Mark McClellan tells The Pink Sheet a robust real-world evidence infrastructure is needed, and that RWE studies should be used to fill in evidence gaps post-approval. To read the report, click here. (Paid subscription required) […]
Gupta: Five Trends That Have Accelerated in 2020
Heron Therapeutics' Anita Gupta in a recent piece published on Forbes highlights five key trends that have accelerated during the COVID-19 pandemic. In addition to greater efforts to bolster efficiency using data analytics, Gupta writes the following trends have generated much momentum: […]
ICER Posts White Paper on Alternative Pricing Policies During Pandemic
The Institute for Clinical and Economic Review (ICER) announced the release of a new white paper on alternative policies for pricing drugs and vaccines during a pandemic. ICER is also set to host a three-part online series in which experts will discuss the advantages and disadvantages of […]
Study Finds Inconsistent Reimbursement Assessments Across EU Markets
While some modifications in the HTA process for orphan drugs have had some positive impacts, manufacturers still face key hurdles due to inconsistent reimbursement assessments in the EU markets, the authors of a recent study suggest. The authors, Chales River Associates' Steven Kelly, Ioanna […]
ICER Cancels Meeting for Non-Alcoholic Steatohepatitis Assessment
The Institute for Clinical and Economic Review (ICER) has canceled the August meeting of the Midwest CEPAC. The meeting was set to discuss the effectiveness and value of obeticholic acid for the treatment of non-alcoholic steatohepatitis. "This decision is the result of the Food and Drug […]
ISPOR Course on Payment Models Nears
Registration is still open for the International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) upcoming short course on risk-sharing and performance-based payment models. The intermediate course is set for 10 a.m. EST July 8. "Although these agreements have an intrinsic appeal, […]
ISPOR Short Course on Medical Devices is Tomorrow
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) short course on market access and value assessment of medical devices is tomorrow (July 2). The online, 4-hour event is set to begin 10 a.m. EST. "Experience in launching pharmaceutical products can present both […]
Webinar on Future of Primary Care Set for July 28
World Congress is set to host a webinar July 28 on the future of primary care. The hour-long event, "The Future of Primary Care: How Providers Can Adapt to Changing Patient Demands, Gain Flexibility, and Develop Economic Stability," is set to begin 2 p.m. EST. Featured speakers include: […]
Blog Post Explores Key Issues in De-Implementation
The last installment of a four-part blog series by AcademyHealth's Research Community on Low-Value Care looks at some key hurdles health systems must tackle in the de-implementation process. Scalability is one such challenge Moriah Ellen, Ben Gurion University, and Christian Helfrich, […]
Siami: NESTcc at ‘Pivot Point’
Sandra Siami, the new head of the National Evaluation System for health Technology Coordinating Center (NESTcc), tells MedTech Dive the organization is at a "pivot point." "First and foremost, we're at a pivot point in being able to demonstrate success," she said in an interview. "Having […]
Thompson Spotlights Virtual Research
Syneos Health's David Thompson in a recent Value & Outcomes Spotlight article spotlights how drugmakers are dealing with increased emphasis on virtual research. The COVID-19 pandemic, he writes, has ultimately ramped up the incorporation of more digital approaches in the clinical research […]
PRMA’s Chadwick Highlights Common Omissions in Global Value Dossiers
PRMA Consulting HTA Manager Claire Chadwick in a recent blog post discusses five common omissions in global value dossiers. Chadwick says the following five omissions lead to less robust dossiers: Inadequate justification Insufficient trial and analysis information Poor consideration […]
Value & Outcomes Spotlight Editor-in-Chief Bids Farewell in Latest Issue
Value & Outcomes Spotlight Editor-in-Chief David Thompson bid readers farewell in the latest issue, describing his 12-plus years in the position as "extremely gratifying." "I also look forward to connecting with friends and colleagues throughout the ISPOR community as circumstances permit us […]
Report: Responses to Remdesivir Price Mostly Negative
Even though the Institute for Clinical for Economic Review (ICER) announced its support of remdesivir's pricing, the response has been mostly negative, FiercePharma reports. West Health Policy Center Health Policy Director Sean Dickson said the pricing announcement confirmed a majority of […]
Healthcare Reimbursement Market to Reach $20 billion by 2025, Report Suggests
The U.S. healthcare reimbursement market could be valued at $20 billion by 2025, according to a new report by Brand Essence Market Research. "Growing level of costs associated with the healthcare services and products, increasing prevalence and organizing of government-led healthcare programs are […]
Report: FDA Mandates 50% Efficacy for COVID-19 Vaccines
Vaccine candidates must be at least 50 percent more effective than a placebo to be considered for Food and Drug Administration approval, according to a FiercePharma report. However, some experts have expressed concerns about that guidance, according to the report, with some suggesting that level […]
Pandemic Puts Pressure on FDA on RWD
The COVID-19 pandemic has put increased pressure on the Food and Drug Administration's real-world data initiatives. According to a Pink Sheet report, the agency is set to hear from stakeholders on its data plans. To read the report, click here.(Paid subscription required) […]
Mental Care Utilization Poised to be Key Driver of Health Spending Next Year
PwC in a new analysis suggests utilization of mental care services will be a key driver of health spending next year, HealthPayerIntelligence reports. The analysis also found, however, that increased use of telehealth services could offer some balance to rising prices. "In 2021, HRI expects […]
Report on PBM Market Forecasts 7% CAGR Between 2019-2025
A new report from Arizton forecasts a compound annual growth rate of 7 percent for the pharmacy benefit management market between 2019-2025. The report spotlights a number of companies, including Abarca Health, BeneCard PBF, CVS Caremark and Express Scripts. "With a high number of consumers […]
